The Vitreomacular Adhesion (VMA) market is a subset of the Optical market that focuses on the diagnosis and treatment of vitreomacular adhesion, a condition in which the vitreous gel of the eye adheres to the macula. VMA can cause a variety of vision-related issues, including blurred vision, metamorphopsia, and decreased visual acuity. Treatment options for VMA include pharmacological agents, laser therapy, and vitrectomy.
The VMA market is expected to grow due to the increasing prevalence of age-related macular degeneration, the introduction of new treatments, and the increasing demand for minimally invasive treatments. Additionally, the increasing awareness of VMA and its associated symptoms is expected to drive the market.
Companies in the VMA market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Nidek, Optos, and Topcon. Show Less Read more
